These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32217863)

  • 1. Life-Threatening Serotonin Syndrome Precipitated by Discontinuation of Serotonin-Dopamine Antagonist in the Presence of Serotonergic Agents: A Case Report.
    Ishida T; Uchida H; Kaneko S; Sugiyama K; Hamabe Y; Mimura M; Suzuki T
    Clin Neuropharmacol; 2020; 43(3):81-83. PubMed ID: 32217863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed Serotonin Syndrome in the Setting of a Mixed Fluoxetine and Serotonin Antagonist Overdose.
    Little K; Lin CM; Reynolds PM
    Am J Case Rep; 2018 May; 19():604-607. PubMed ID: 29795058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case of Serotonin Syndrome Initially Presenting as Diffuse Body Pain.
    Guo MH; Monir RL; Wright A; Holland NP
    Am J Case Rep; 2018 Oct; 19():1227-1231. PubMed ID: 30318504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Probable Serotonin Syndrome and Withdrawal Symptoms Caused by Milnacipran].
    Koshiishi T; Okuyama K
    Yakugaku Zasshi; 2016; 136(12):1675-1679. PubMed ID: 27904101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of milnacipran-associated morbilliform rash and serotonin toxicity.
    Huskey AM; Thomas CC; Waddell JA
    Ann Pharmacother; 2013; 47(7-8):e32. PubMed ID: 23837199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin Syndrome From Duloxetine Monotherapy: A Case Report.
    Li L; Mi Q
    Cureus; 2023 Jun; 15(6):e40933. PubMed ID: 37496538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological characteristics of perospirone hydrochloride, a novel antipsychotic agent].
    Ohno Y
    Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):225-31. PubMed ID: 11084919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perospirone therapy in elderly patients with schizophrenia].
    Masui T; Honma H; Kondo C; Osawa T; Iwasaki S; Matsubara S
    Seishin Shinkeigaku Zasshi; 2003; 105(10):1247-53. PubMed ID: 14679781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Headache as a presenting feature in patients with serotonin syndrome: a case series.
    Prakash S; Belani P; Trivedi A
    Cephalalgia; 2014 Feb; 34(2):148-53. PubMed ID: 23827981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic medications, herbal supplements, and perioperative serotonin syndrome.
    Warner ME; Naranjo J; Pollard EM; Weingarten TN; Warner MA; Sprung J
    Can J Anaesth; 2017 Sep; 64(9):940-946. PubMed ID: 28667541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin syndrome associated with polypharmacy in the elderly.
    Poeschla BD; Bartle P; Hansen KP
    Gen Hosp Psychiatry; 2011; 33(3):301.e9-11. PubMed ID: 21601732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of 5-HT2 and D2 receptor interaction in the atypical antipsychotic action of the novel succimide derivative, perospirone.
    Ohno Y; Ishida-Tokuda K; Ishibashi T; Sakamoto H; Tagashira R; Horisawa T; Yabuuti K; Matsumoto K; Kawabe A; Nakamura M
    Pol J Pharmacol; 1997 Aug; 49(4):213-9. PubMed ID: 9437764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fentanyl-Induced Serotonin Syndrome 5 Days After Cessation of Serotonergic Agents: A Case Report.
    Siddiqui A; Agrawal S; Sekhri N
    A A Pract; 2023 Nov; 17(11):e01720. PubMed ID: 37934660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lorcaserin in Obese and Overweight Patients Taking Prohibited Serotonergic Agents: A Retrospective Analysis.
    Nguyen CT; Zhou S; Shanahan W; Fain R
    Clin Ther; 2016 Jun; 38(6):1498-1509. PubMed ID: 27206567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of serotonin syndrome in patients treated with fentanyl on serotonergic agents.
    Koury KM; Tsui B; Gulur P
    Pain Physician; 2015; 18(1):E27-30. PubMed ID: 25675067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of perospirone (SM-9018), a novel serotonin-2 and dopamine-2 receptor antagonist, and other antipsychotics in the conditioned fear stress-induced freezing behavior model in rats.
    Ishida-Tokuda K; Ohno Y; Sakamoto H; Ishibashi T; Wakabayashi J; Tojima R; Morita T; Nakamura M
    Jpn J Pharmacol; 1996 Oct; 72(2):119-26. PubMed ID: 8912913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible serotonin syndrome with carbidopa-levodopa and linezolid.
    Pettit NN; Alonso V; Wojcik E; Anyanwu EC; Ebara L; Benoit JL
    J Clin Pharm Ther; 2016 Feb; 41(1):101-3. PubMed ID: 26813986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of perospirone (SM-9018), a potential atypical neuroleptic, on dopamine D1 receptor-mediated vacuous chewing movement in rats: a role of 5-HT2 receptor blocking activity.
    Ohno Y; Ishida-Tokuda K; Ishibashi T; Nakamura M
    Pharmacol Biochem Behav; 1997 Aug; 57(4):889-95. PubMed ID: 9259021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Serotonin Syndrome Precipitated by Quetiapine in a Middle-Aged Female on Trazodone and Sertraline.
    Varma S; Xavier S; Desai S; Ali S
    Cureus; 2022 Aug; 14(8):e27668. PubMed ID: 36072169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perospirone in treatment of Huntington's disease: a first case report.
    Roppongi T; Togo T; Nakamura S; Asami T; Yoshimi A; Shiozaki K; Kato D; Kawanishi C; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):308-10. PubMed ID: 16887250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.